Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1363525
PUBLISHER: Grand View Research | PRODUCT CODE: 1363525
U.S. And Europe Digital Pathology Market Size, Share & Trends Analysis Report By End-use (Hospitals, Diagnostic Labs), By Product (Software, Device), By Application (Disease Diagnosis, Academic Research), And Segment Forecasts, 2023 - 2030
PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
U.S. And Europe Digital Pathology Market Growth & Trends:
The U.S and Europe digital pathology market size is expected to reach USD 994.0 million by 2030, registering a CAGR of 7.2% over the forecast period, according to a new study by Grand View Research, Inc.. Digital pathology encompasses the capture, organization, dissemination, and analysis of pathology data and slides within a digital framework.Digital pathology enables high-resolution imaging and advanced visualization tools, allowing pathologists to examine tissue samples in greater detail. This leads to more accurate and precise diagnoses, especially for complex or rare cases. New digital pathology technologies are developing to enhance the communication between the collection of samples and the creation of pathology reports with updated data.
One such technology is Multiplexing. It is a cutting-edge technique for locating or quantifying several proteins in a single material. The discipline of digital pathology is projected to undergo a revolution as a result of the incorporation of cutting-edge multiplexing techniques, such as automated multispectral slide imaging. Some of the other techniques include the use of automated molecular fluorescent tagging and imaging systems, merging qdots with multispectral imaging, etc. The use of these cutting-edge imaging techniques in digital pathology has the potential to raise diagnostic precision, decrease workloads, boost productivity, and more effectively integrate digital pictures into information systems, thereby driving the market. Furthermore, various initiatives are been undertaken to promote and integrate digital pathology into the healthcare systems.
These initiatives are aimed at leveraging technology for improved patient care, research, and education. For instance, in March 2022, the National Pathology Imaging Co-operative (NPIC) created prospects for NHS trusts across the nation to transition to digital pathology, thereby enhancing patient diagnoses. This initiative is fueled by recent funding and the broader implementation of Sectra's digital pathology solution and Vendor Neutral Archive (VNA). Furthermore, prominent players are focusing on various strategies, including partnerships, novel product innovations, research collaborations, and mergers and acquisitions, as avenues to gain a competitive edge. For instance, in July 2020, Paige, a player in computational pathology, obtained clearance from the U.S. FDA (510(k)) for its FullFocus digital pathology image viewer designed for primary diagnoses.
This clearance authorized the in vitro diagnostic (IVD) application of FullFocus, in conjunction with Philips' Ultra-Fast Scanner. In August 2023, Paige entered into a collaborative effort with Ohio State University Wexner Medical Center and its associated community hospitals. This collaboration involves a multi-arm study to assess the clinical utility, health economics, and impact on accuracy, efficiency, and cost savings of utilizing AI tools in diagnosing cancer within a community hospital environment. OSWMC will deploy the Paige Prostate Suite, which includes the FDA-approved AI-powered pathology algorithm known as Paige Prostate Detect. The study aims to evaluate disparities between diagnoses made with and without AI assistance. Such initiatives are expected to fuel the market growth over a forecast period.
U.S. And Europe Digital Pathology Market Report Highlights:
- In 2022, the device segment accounted for the largest market share of 51.9%.Digital pathology devices offer high-resolution imaging and advanced visualization tools. Also, these devices integrate with electronic health records (EHRs), allowing seamless data exchange and comprehensive patient information, thereby driving the market
- Based on application, the academic research segment accounted for 45.8% of the total share in 2022. Digital pathology provides high-resolution imaging and advanced analysis tools that are particularly valuable for detailed research studies
- Also, it allows easy sharing of images, facilitating collaborative discussions, peer reviews, and interdisciplinary research projects
- The hospitals end-use segment held the largest revenue share of 36.7% in 2022 owing to its rising adoption due to various factors such as improved patient care, streamlined workflows and enhanced diagnostic accuracy
- U.S. accounted for the largest market share of more than 56.3% in 2022. The market is driven by various factors such as the need for improved diagnostic accuracy, the integration of digital solutions with healthcare systems, and advancements in imaging technology
Product Code: GVR-4-68040-129-1
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Research Process
- 1.2. Information Procurement
- 1.2.1. Purchased database:
- 1.2.1.1. GVR's internal database
- 1.2.2. Market Formulation & Validation
- 1.2.1. Purchased database:
- 1.3. Research Methodology
- 1.4. Research Scope and Assumptions
- 1.5. Research Methodology
- 1.5.1. Region Market: CAGR Calculation
- 1.5.2. Region Based Segment Share Calculation
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- 2.4. U.S. and Europe Digital Pathology Market Snapshot
Chapter 3. U.S. and Europe Digital Pathology Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. U.S. and Europe Digital Pathology Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.1. Industry Analysis - Porter's
- 3.4. Impact of COVID-19 on U.S. and Europe Digital Pathology Market
Chapter 4. U.S. and Europe Digital Pathology Market: Product Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. U.S. and Europe Digital Pathology Market: Product Movement Analysis, USD Million, 2022 & 2030
- 4.2.1. Software
- 4.2.1.1. Software Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.2. Device
- 4.2.2.1. Device Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.2.2. Scanners
- 4.2.2.2.1. Scanners Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.2.3. Slide Management Systems
- 4.2.2.3.1. Slide Management Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.3. Storage Systems
- 4.2.3.1. Storage Systems Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 4.2.1. Software
Chapter 5. U.S. and Europe Digital Pathology Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. U.S. and Europe Digital Pathology Market: Application Movement Analysis, USD Million, 2022 & 2030
- 5.2.1. Drug Discovery & Development
- 5.2.1.1. Drug Discovery & Development Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.2.2. Academic Research
- 5.2.2.1. Academic Research Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.2.3. Disease Diagnosis
- 5.2.3.1. Disease Diagnosis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.2.3.2. Cancer Cell Detection
- 5.2.3.2.1. Cancer Cell Detection Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.2.3.3. Others
- 5.2.3.3.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 5.2.1. Drug Discovery & Development
Chapter 6. U.S. and Europe Digital Pathology Market: End-use Type Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. U.S. and Europe Digital Pathology Market: End-use Movement Analysis, USD Million, 2022 & 2030
- 6.2.1. Hospitals
- 6.2.1.1. Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. Biotech and Pharma Companies
- 6.2.2.1. Biotech and Pharma Companies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Diagnostics Labs
- 6.2.3.1. Diagnostics Labs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.4. Academic & Research Institutes
- 6.2.4.1. Academic and Research Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 6.2.1. Hospitals
Chapter 7. U.S. and Europe Digital Pathology Market: Regional Estimates & Trend Analysis
- 7.1. Definition & Scope
- 7.2. Regional Market Share Analysis, 2022 & 2030
- 7.3. Regional Market Dashboard
- 7.4. Regional Market Snapshot
- 7.5. Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
- 7.6. U.S.
- 7.6.1. U.S. Digital Pathology Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.1.1. Key Country Dynamics
- 7.6.1.2. Regulatory Framework
- 7.6.1.3. U.S. Digital Pathology Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.1. U.S. Digital Pathology Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7. Europe
- 7.7.1. Europe Digital Pathology Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.2. UK
- 7.7.2.1.1. Key Country Dynamics
- 7.7.2.1.2. Regulatory Framework
- 7.7.2.1.3. UK Digital Pathology Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.3. Germany
- 7.7.3.1.1. Key Country Dynamics
- 7.7.3.1.2. Regulatory Framework
- 7.7.3.1.3. Germany Digital Pathology Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.4. France
- 7.7.4.1.1. Key Country Dynamics
- 7.7.4.1.2. Regulatory Framework
- 7.7.4.1.3. France Digital Pathology Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.5. Italy
- 7.7.5.1.1. Key Country Dynamics
- 7.7.5.1.2. Regulatory Framework
- 7.7.5.1.3. Italy Digital Pathology Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.6. Spain
- 7.7.6.1.1. Key Country Dynamics
- 7.7.6.1.2. Regulatory Framework
- 7.7.6.1.3. Spain Digital Pathology Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.7. Russia
- 7.7.7.1.1. Key Country Dynamics
- 7.7.7.1.2. Regulatory Framework
- 7.7.7.1.3. Russia Digital Pathology Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.8. Sweden
- 7.7.8.1.1. Key Country Dynamics
- 7.7.8.1.2. Regulatory Framework
- 7.7.8.1.3. Sweden Digital Pathology Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.9. The Netherlands
- 7.7.9.1.1. Key Country Dynamics
- 7.7.9.1.2. Regulatory Framework
- 7.7.9.1.3. The Netherlands Digital Pathology Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.10. Switzerland
- 7.7.10.1.1. Key Country Dynamics
- 7.7.10.1.2. Regulatory Framework
- 7.7.10.1.3. Switzerland Digital Pathology Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Recent Development and Impact Analysis, by key Market Participants
- 8.3. Company Profiles
- 8.3.1. Leica Biosystems Nussloch GmbH (Danaher)
- 8.3.1.1. Company Overview
- 8.3.1.2. Financial Performance
- 8.3.1.3. Product Benchmarking
- 8.3.1.4. Strategic initiatives
- 8.3.2. Hamamatsu Photonics, Inc.
- 8.3.2.1. Company Overview
- 8.3.2.2. Financial Performance
- 8.3.2.3. Product Benchmarking
- 8.3.2.4. Strategic initiatives
- 8.3.3. Koninklijke Philips N.V.
- 8.3.3.1. Company Overview
- 8.3.3.2. Financial Performance
- 8.3.3.3. Product Benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. Olympus Corporation
- 8.3.4.1. Company Overview
- 8.3.4.2. Financial Performance
- 8.3.4.3. Product Benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. F. Hoffmann-La Roche Ltd.
- 8.3.5.1. Company Overview
- 8.3.5.2. Financial Performance
- 8.3.5.3. Product Benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Mikroscan Technologies, Inc.
- 8.3.6.1. Company Overview
- 8.3.6.2. Financial Performance
- 8.3.6.3. Product Benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Inspirata, Inc.
- 8.3.7.1. Company Overview
- 8.3.7.2. Financial Performance
- 8.3.7.3. Product Benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Epredia (3DHISTECH Ltd.)
- 8.3.8.1. Company Overview
- 8.3.8.2. Financial Performance
- 8.3.8.3. Product Benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Visiopharm A/S
- 8.3.9.1. Company Overview
- 8.3.9.2. Financial Performance
- 8.3.9.3. Product Benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Huron Technologies International Inc.
- 8.3.10.1. Company Overview
- 8.3.10.2. Financial Performance
- 8.3.10.3. Product Benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. ContextVision AB
- 8.3.11.1. Company Overview
- 8.3.11.2. Financial Performance
- 8.3.11.3. Product Benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Owkin
- 8.3.12.1. Company Overview
- 8.3.12.2. Financial Performance
- 8.3.12.3. Product Benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. Lunit
- 8.3.13.1. Company Overview
- 8.3.13.2. Financial Performance
- 8.3.13.3. Product Benchmarking
- 8.3.13.4. Strategic initiatives
- 8.3.14. Tempus Labs
- 8.3.14.1. Company Overview
- 8.3.14.2. Financial Performance
- 8.3.14.3. Product Benchmarking
- 8.3.14.4. Strategic initiatives
- 8.3.15. DeepBio
- 8.3.15.1. Company Overview
- 8.3.15.2. Financial Performance
- 8.3.15.3. Product Benchmarking
- 8.3.15.4. Strategic initiatives
- 8.3.1. Leica Biosystems Nussloch GmbH (Danaher)
Product Code: GVR-4-68040-129-1
List of Tables
- Table 1 List of secondary sources
- Table 2 List of abbreviation
- Table 3 U.S. and Europe Digital Pathology Market estimates and forecasts, by Product type, 2018 - 2030 (USD Million)
- Table 4 U.S. and Europe Digital Pathology Market estimates and forecasts, by Application type, 2018 - 2030 (USD Million)
- Table 5 U.S. and Europe Digital Pathology Market estimates and forecasts, by End Use type, 2018 - 2030 (USD Million)
- Table 6 U.S. Digital Pathology Market estimates and forecasts, by Product type, 2018 - 2030 (USD Million)
- Table 7 U.S. Digital Pathology Market estimates and forecasts, by Application type, 2018 - 2030 (USD Million)
- Table 8 U.S. Digital Pathology Market estimates and forecasts, by End Use type, 2018 - 2030 (USD Million)
- Table 9 Europe Digital Pathology Market estimates and forecasts, by Product type, 2018 - 2030 (USD Million)
- Table 10 Europe Digital Pathology Market estimates and forecasts, by Application type, 2018 - 2030 (USD Million)
- Table 11 Europe Digital Pathology Market estimates and forecasts, by End Use type, 2018 - 2030 (USD Million)
- Table 12 UK Digital Pathology Market estimates and forecasts, by Product type, 2018 - 2030 (USD Million)
- Table 13 UK Digital Pathology Market estimates and forecasts, by Application type, 2018 - 2030 (USD Million)
- Table 14 UK Digital Pathology Market estimates and forecasts, by End Use type, 2018 - 2030 (USD Million)
- Table 15 Germany Digital Pathology Market estimates and forecasts, by Product type, 2018 - 2030 (USD Million)
- Table 16 Germany Digital Pathology Market estimates and forecasts, by Application type, 2018 - 2030 (USD Million)
- Table 17 Germany Digital Pathology Market estimates and forecasts, by End Use type, 2018 - 2030 (USD Million)
- Table 18 France Digital Pathology Market estimates and forecasts, by Product type, 2018 - 2030 (USD Million)
- Table 19 France Digital Pathology Market estimates and forecasts, by Application type, 2018 - 2030 (USD Million)
- Table 20 France Digital Pathology Market estimates and forecasts, by End Use type, 2018 - 2030 (USD Million)
- Table 21 Italy Digital Pathology Market estimates and forecasts, by Product type, 2018 - 2030 (USD Million)
- Table 22 Italy Digital Pathology Market estimates and forecasts, by Application type, 2018 - 2030 (USD Million)
- Table 23 Italy Digital Pathology Market estimates and forecasts, by End Use type, 2018 - 2030 (USD Million)
- Table 24 Spain Digital Pathology Market estimates and forecasts, by Product type, 2018 - 2030 (USD Million)
- Table 25 Spain Digital Pathology Market estimates and forecasts, by Application type, 2018 - 2030 (USD Million)
- Table 26 Spain Digital Pathology Market estimates and forecasts, by End Use type, 2018 - 2030 (USD Million)
- Table 27 Sweden Digital Pathology Market estimates and forecasts, by Product type, 2018 - 2030 (USD Million)
- Table 28 Sweden Digital Pathology Market estimates and forecasts, by Application type, 2018 - 2030 (USD Million)
- Table 29 Sweden Digital Pathology Market estimates and forecasts, by End Use type, 2018 - 2030 (USD Million)
- Table 30 Switzerland Digital Pathology Market estimates and forecasts, by Product type, 2018 - 2030 (USD Million)
- Table 31 Switzerland Digital Pathology Market estimates and forecasts, by Application type, 2018 - 2030 (USD Million)
- Table 32 Switzerland Digital Pathology Market estimates and forecasts, by End Use type, 2018 - 2030 (USD Million)
- Table 33 The Netherlands Digital Pathology Market estimates and forecasts, by Product type, 2018 - 2030 (USD Million)
- Table 34 The Netherlands Digital Pathology Market estimates and forecasts, by Application type, 2018 - 2030 (USD Million)
- Table 35 The Netherlands Digital Pathology Market estimates and forecasts, by End Use type, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information procurement
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Value-chain-based sizing & forecasting
- Fig. 6 QFD modeling for market share assessment
- Fig. 7 Market formulation & validation
- Fig. 8 Commodity Flow Analysis
- Fig. 9 U.S. and Europe Digital Pathology Market snapshot (2022)
- Fig. 10 U.S. and Europe Digital Pathology Market segmentation
- Fig. 11 Market trends and outlook
- Fig. 12 Parent market outlook
- Fig. 13 Related/ancillary market outlook
- Fig. 14 Penetration & growth prospect mapping
- Fig. 15 Market driver relevance analysis (Current & future impact)
- Fig. 16 Market restraint relevance analysis (Current & future impact)
- Fig. 17 U.S. and Europe Digital Pathology Market, Product type outlook: key takeaways (USD Million)
- Fig. 18 U.S. and Europe Digital Pathology Market: Product movement analysis, 2022 & 2030 (USD Million)
- Fig. 19 Software market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 20 Device market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 21 Scanners market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 22 Slide management system market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 23 Storage Systems market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 24 U.S. and Europe Digital Pathology Market Application type outlook: key takeaways (USD Million)
- Fig. 25 U.S. and Europe Digital Pathology Market: Application movement analysis, 2022 & 2030 (USD Million)
- Fig. 26 Drug discovery and development market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 27 Academic research market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 28 Disease diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 29 Cancer cell detection market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 31 U.S. and Europe Digital Pathology Market, End Use type outlook: key takeaways (USD Million)
- Fig. 32 U.S. and Europe Digital Pathology Market: End Use movement analysis, 2022 & 2030 (USD Million)
- Fig. 33 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 34 Biotech and Pharma companies market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 35 Diagnostics labs market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 36 Academic and research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 37 U.S. and Europe Digital Pathology Market, regional marketplace: Key takeaways (USD Million)
- Fig. 38 U.S. and Europe Digital Pathology Market: regional movement analysis, 2022 & 2030 (USD Million)
- Fig. 39 U.S. Digital Pathology Market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 40 Europe Digital Pathology Market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 41 Germany Digital Pathology Market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 42 UK Digital Pathology Market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 43 France Digital Pathology Market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 44 Spain Digital Pathology Market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 45 Italy Digital Pathology Market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 46 Russia Digital Pathology Market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 47 Netherlands U.S. and Europe Digital Pathology Market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 48 Switzerland Digital Pathology Market estimates and forecasts, 2018 - 2030 (USD Million)
- Fig. 49 Sweden Digital Pathology Market estimates and forecasts, 2018 - 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.